About Enhancer

Enhancer ID: E_01_0996
Species: human
Position : chr5:88714648-88716648
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Endometrial cancer
Pubmed ID:  32186750
Enhancer experiment: RT-qPCR, DNA methylation analysis, cell viability assay, Western blot
Enhancer experiment description: EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed.

About TF

TF name : MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2)
TF experiment: RT-QPCR?DNA?????????????Western blot
TF experiment description: EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed.

About Function

Enhancer function : EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
EC cell lines transfected with vectors overexpressing miR?638, its target gene myocyte enhancer factor 2C (MEF2C) or both, were constructed.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF


Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs